Jyseleca 100 mg and 200 mg film-coated tablets *

  • Company:

    Gilead Sciences Ltd
  • Status:

    No Recent Update
  • Legal Category:

    Product subject to medical prescription which may not be renewed (A)
  • Active Ingredient(s):

    This medicinal product is subject to additional monitoring.

    *Additional information is available within the SPC or upon request to the company

When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 07 May 2021

File name

Jyseleca SmPC - April 2021_1620394832.pdf

Reasons for updating

  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 5.2 - Pharmacokinetic properties

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 07 May 2021

File name

Jyseleca PIL - April 2021_1620394790.pdf

Reasons for updating

  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 6 - date of revision
  • Addition of information on reporting a side effect.

EDM Updated on 10 October 2020

File name

Jyseleca Patient Alert Card (Ireland) UK-INF-2020-08-0020_1602344862.pdf

Reasons for updating

  • Add New Doc

EDM Updated on 10 October 2020

File name

Jyseleca HCP Guide (Ireland) UK-INF-2020-08-0019_1602344862.pdf

Reasons for updating

  • Add New Doc

Updated on 05 October 2020

File name

Jyseleca PIL -Sep 2020_1601905338.pdf

Reasons for updating

  • New PIL for new product

Updated on 05 October 2020

File name

Jyseleca SmPC -Sep 2020_1601905298.pdf

Reasons for updating

  • New SPC for new product

Legal category:Product subject to medical prescription which may not be renewed (A)